Free Trial
→ Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th... (From Banyan Hill Publishing) (Ad)tc pixel Free REZI Stock Alerts

Resideo Technologies (REZI) Financials

Resideo Technologies logo
$30.97 +0.36 (+1.17%)
As of 02:04 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Resideo Technologies

Annual Income Statements for Resideo Technologies

This table shows Resideo Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 177 -394 405 36 37 242 283 210 91 -562
Consolidated Net Income / (Loss)		 177 -394 405 36 37 242 283 210 116 -527
Net Income / (Loss) Continuing Operations		 177 -394 405 36 37 242 283 210 116 -527
Total Pre-Tax Income 		310 166 104 71 101 353 418 313 221 -457
Total Operating Income		 495 445 493 258 311 559 611 547 520 607
Total Gross Profit		 1,365 1,316 1,425 1,277 1,344 1,584 1,766 1,696 1,901 2,196
Total Revenue		 4,455 4,519 4,827 4,988 5,071 5,846 6,370 6,242 6,761 7,472
Operating Revenue		 4,455 4,519 4,827 4,988 5,071 5,846 6,370 6,242 6,761 7,472
Total Cost of Revenue		 3,090 3,203 3,402 3,711 3,727 4,262 4,604 4,546 4,860 5,276
Operating Cost of Revenue		 3,090 3,203 3,402 3,711 3,727 4,262 4,604 4,546 4,860 5,276
Total Operating Expenses		 870 871 932 1,019 1,033 1,025 1,155 1,149 1,381 1,589
Selling, General & Admin Expense		 870 871 932 932 889 909 974 960 1,138 1,266
Research & Development Expense		 - - - - 74 86 111 109 111 167
Amortization Expense		 - - - - 30 30 35 38 80 122
Other Operating Expenses / (Income)		 - - - 87 - - - - - 18
Restructuring Charge		 - - - - 40 0.00 35 42 52 16
Total Other Income / (Expense), net		 -185 -279 -389 -187 -210 -206 -193 -234 -299 -1,064
Interest Expense		 0.00 0.00 20 69 63 47 54 65 81 135
Other Income / (Expense), net		 -185 -279 -369 -118 -147 -159 -139 -169 -218 -929
Income Tax Expense		 133 560 -301 35 64 111 135 103 105 70
Preferred Stock Dividends Declared		 - - - - - - 0.00 0.00 19 35
Net Income / (Loss) Attributable to Noncontrolling Interest		 - - - - - - 0.00 0.00 6.00 0.00
Basic Earnings per Share		 $1.44 ($3.22) $3.31 $0.29 $0.30 $1.68 $1.94 $1.43 $0.62 ($3.77)
Weighted Average Basic Shares Outstanding		 122.50M 122.50M 122.50M 122.72M 125M 144M 146M 147M 146M 149M
Diluted Earnings per Share		 $1.44 ($3.22) $3.30 $0.29 $0.29 $1.63 $1.90 $1.42 $0.61 ($3.77)
Weighted Average Diluted Shares Outstanding		 122.50M 122.50M 122.62M 123.24M 126M 148M 149M 148M 149M 149M
Weighted Average Basic & Diluted Shares Outstanding		 - 122.40M 122.40M 122.94M 143.14M 145.02M 146.62M 145.32M 147.88M 151.25M

Quarterly Income Statements for Resideo Technologies

This table shows Resideo Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/30/2024 6/29/2024 9/28/2024 12/31/2024 3/29/2025 6/28/2025 9/27/2025 12/31/2025 4/4/2026
Net Income / (Loss) Attributable to Common Shareholders		 21 82 43 28 11 7.00 -3.00 -833 131 143 26
Consolidated Net Income / (Loss)		 21 82 43 30 20 23 6.00 -825 156 136 38
Net Income / (Loss) Continuing Operations		 21 82 43 30 20 23 6.00 -825 156 136 38
Total Pre-Tax Income 		37 101 73 59 44 45 15 -738 110 156 55
Total Operating Income		 109 147 128 122 126 144 136 177 154 140 102
Total Gross Profit		 417 425 400 447 524 530 511 569 556 560 551
Total Revenue		 1,554 1,537 1,486 1,589 1,828 1,858 1,770 1,943 1,864 1,895 1,912
Operating Revenue		 1,554 1,537 1,486 1,589 1,828 1,858 1,770 1,943 1,864 1,895 1,912
Total Cost of Revenue		 1,137 1,112 1,086 1,142 1,304 1,328 1,259 1,374 1,308 1,335 1,361
Operating Cost of Revenue		 1,137 1,112 1,086 1,142 1,304 1,328 1,259 1,374 1,308 1,335 1,361
Total Operating Expenses		 308 278 272 325 398 386 375 392 402 420 449
Selling, General & Admin Expense		 233 241 231 280 317 310 306 319 324 317 340
Research & Development Expense		 28 27 25 21 23 42 35 41 44 47 48
Amortization Expense		 9.00 10 9.00 13 29 29 30 30 31 31 31
Restructuring Charge		 - - 7.00 11 29 - 4.00 2.00 3.00 7.00 30
Total Other Income / (Expense), net		 -72 -46 -55 -63 -82 -99 -121 -915 -44 16 -47
Interest Expense		 16 15 13 15 27 26 25 24 37 49 47
Other Income / (Expense), net		 -56 -31 -42 -48 -55 -73 -96 -891 -7.00 65 0.00
Income Tax Expense		 16 19 30 29 24 22 9.00 87 -46 20 17
Preferred Stock Dividends Declared		 0.00 - 0.00 2.00 8.00 - 9.00 8.00 9.00 9.00 9.00
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.00 - - - 1.00 - 0.00 - 16 - 3.00
Basic Earnings per Share		 $0.14 $0.56 $0.29 $0.19 $0.07 $0.07 ($0.02) ($5.59) $0.88 $0.96 $0.17
Weighted Average Basic Shares Outstanding		 147M 147M 146M 146M 147M 146M 148M 149M 149M 149M 151M
Diluted Earnings per Share		 $0.14 $0.56 $0.29 $0.19 $0.07 $0.06 ($0.02) ($5.59) $0.85 $0.99 $0.17
Weighted Average Diluted Shares Outstanding		 148M 148M 148M 149M 149M 149M 148M 149M 154M 149M 155M
Weighted Average Basic & Diluted Shares Outstanding		 146.09M 145.32M 146.02M 146.41M 146.97M 147.88M 148.50M 148.76M 149.71M 151.25M 151.43M

Annual Cash Flow Statements for Resideo Technologies

This table details how cash moves in and out of Resideo Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -35 9.00 209 -143 395 262 -450 308 56 -31
Net Cash From Operating Activities		 151 37 462 23 244 315 152 440 444 -1,137
Net Cash From Continuing Operating Activities		 151 37 462 23 244 315 152 440 444 -1,137
Net Income / (Loss) Continuing Operations		 177 -394 405 36 37 242 283 210 116 -527
Consolidated Net Income / (Loss)		 177 -394 405 36 37 242 283 210 116 -527
Depreciation Expense		 57 67 66 80 86 88 94 98 144 195
Non-Cash Adjustments To Reconcile Net Income		 34 41 66 8.00 90 83 91 82 158 -546
Changes in Operating Assets and Liabilities, net		 -124 323 -75 -101 31 -98 -316 50 26 -259
Net Cash From Investing Activities		 -191 -51 -74 -112 -103 -65 -764 -44 -1,409 -39
Net Cash From Continuing Investing Activities		 -191 -51 -74 -112 -103 -65 -764 -44 -1,409 -39
Purchase of Property, Plant & Equipment		 -60 -51 -81 -95 -70 -63 -85 -105 -80 -116
Acquisitions		 -131 0.00 0.00 -17 -35 -11 -665 -16 -1,337 0.00
Divestitures		 - - - - - 0.00 0.00 86 0.00 77
Other Investing Activities, net		 - 0.00 7.00 0.00 2.00 9.00 -14 -9.00 8.00 0.00
Net Cash From Financing Activities		 4.00 21 -167 -53 253 20 170 -64 1,031 1,128
Net Cash From Continuing Financing Activities		 4.00 21 -167 -53 253 20 170 -64 1,031 1,128
Repayment of Debt		 -2.00 2.00 -29 -26 -26 -1,230 -30 -6.00 -597 -9.00
Repurchase of Common Equity		 - - - - - 0.00 0.00 -41 -1.00 0.00
Payment of Dividends		 - - - - - - 0.00 0.00 -12 -35
Issuance of Debt		 2.00 0.00 1,212 -27 0.00 1,250 200 0.00 1,176 1,201
Issuance of Preferred Equity		 - - - - - - 0.00 0.00 482 0.00
Other Financing Activities, net		 4.00 19 -1,350 0.00 - - - -17 -17 -29
Other Net Changes in Cash		 - 2.00 -12 -1.00 - -8.00 -8.00 - - 17

Quarterly Cash Flow Statements for Resideo Technologies

This table details how cash moves in and out of Resideo Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/30/2024 6/29/2024 9/28/2024 12/31/2024 3/29/2025 6/28/2025 9/27/2025 12/31/2025 4/4/2026
Net Change in Cash & Equivalents		 -13 267 -33 -190 118 161 -115 176 -408 316 -222
Net Cash From Operating Activities		 60 263 2.00 92 147 203 -65 200 -1,571 299 -145
Net Cash From Continuing Operating Activities		 60 263 2.00 92 147 203 -65 200 -1,571 299 -145
Net Income / (Loss) Continuing Operations		 21 82 43 30 20 23 6.00 -825 156 136 38
Consolidated Net Income / (Loss)		 21 82 43 30 20 23 6.00 -825 156 136 38
Depreciation Expense		 22 27 24 28 46 46 47 49 49 50 51
Non-Cash Adjustments To Reconcile Net Income		 49 -8.00 32 22 50 22 79 867 -1,618 126 20
Changes in Operating Assets and Liabilities, net		 -32 162 -97 12 31 112 -197 109 -158 -13 -254
Net Cash From Investing Activities		 -35 46 -22 -1,342 -22 -23 -31 -20 -28 40 -36
Net Cash From Continuing Investing Activities		 -35 46 -22 -1,342 -22 -23 -31 -20 -28 40 -36
Purchase of Property, Plant & Equipment		 -25 -31 -21 -15 -22 -22 -31 -20 -28 -37 -36
Net Cash From Financing Activities		 -29 -17 -8.00 1,060 -9.00 -12 -22 -11 1,192 -31 -42
Net Cash From Continuing Financing Activities		 -29 -17 -8.00 1,060 -9.00 -12 -22 -11 1,192 -31 -42
Repayment of Debt		 -1.00 -4.00 -3.00 -5.00 -590 -12 0.00 -4.00 -1.00 -6.00 -5.00
Payment of Dividends		 - - 0.00 - - - -9.00 -8.00 -9.00 -9.00 -9.00
Issuance of Debt		 - - 2.00 - 582 12 2.00 - 1,209 -10 4.00
Other Financing Activities, net		 - - -7.00 - - - -15 -1.00 -7.00 -6.00 -32
Other Net Changes in Cash		 - - -5.00 - - -7.00 3.00 - -1.00 8.00 1.00

Annual Balance Sheets for Resideo Technologies

This table presents Resideo Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 4,473 4,972 5,128 5,610 5,853 6,387 6,645 8,199 8,433
Total Current Assets		 1,392 1,809 1,785 2,225 2,541 2,502 2,743 3,172 3,358
Cash & Equivalents		 56 265 122 517 775 326 636 692 661
Accounts Receivable		 802 821 817 863 876 1,002 973 1,023 1,073
Inventories, net		 465 628 671 672 740 975 941 1,237 1,354
Other Current Assets		 69 95 175 173 150 199 193 220 270
Plant, Property, & Equipment, net		 265 300 316 318 287 366 390 410 447
Total Noncurrent Assets		 2,816 2,863 3,027 3,067 3,025 3,519 3,512 4,617 4,628
Goodwill		 2,648 2,634 2,642 2,691 2,661 2,724 2,705 3,072 3,100
Intangible Assets		 140 133 - - 120 475 461 1,176 1,091
Other Noncurrent Operating Assets		 23 96 385 376 244 320 346 369 437
Total Liabilities & Shareholders' Equity		 4,473 4,972 5,128 5,610 5,853 6,387 6,645 8,199 8,433
Total Liabilities		 1,870 3,439 3,526 3,617 3,601 3,858 3,896 4,890 5,516
Total Current Liabilities		 1,147 1,489 1,494 1,538 1,494 1,546 1,525 1,790 1,755
Accounts Payable		 738 964 920 936 883 894 905 1,073 1,131
Accrued Expenses		 409 503 552 595 601 640 620 717 624
Total Noncurrent Liabilities		 723 1,950 2,032 2,079 2,107 2,312 2,371 3,100 3,761
Long-Term Debt		 0.00 1,179 1,158 1,155 1,220 1,404 1,396 1,983 3,167
Other Noncurrent Operating Liabilities		 346 771 874 924 887 908 975 1,117 594
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 2,603 1,533 1,602 1,993 2,252 2,529 2,749 3,309 2,917
Total Preferred & Common Equity		 2,603 1,533 1,602 1,993 2,252 2,529 2,749 3,309 2,917
Preferred Stock		 - - - - - - 0.00 482 482
Total Common Equity		 2,603 1,533 1,602 1,993 2,252 2,529 2,749 2,827 2,435
Common Stock		 0.00 1,720 1,761 2,070 2,121 2,176 2,226 2,315 2,391
Retained Earnings		 0.00 2.00 38 75 317 600 810 907 345
Treasury Stock		 - 0.00 -3.00 -6.00 -21 -35 -93 -111 -144
Accumulated Other Comprehensive Income / (Loss)		 -100 -189 -194 -146 -165 -212 -194 -284 -157

Quarterly Balance Sheets for Resideo Technologies

This table presents Resideo Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 10/1/2022 4/1/2023 7/1/2023 9/30/2023 3/30/2024 6/29/2024 9/28/2024 3/29/2025 6/28/2025 9/27/2025 4/4/2026
Total Assets		 6,262 6,399 6,536 6,459 6,520 7,984 8,135 8,074 8,515 8,188 8,207
Total Current Assets		 2,450 2,495 2,622 2,615 2,677 2,884 3,037 3,061 3,392 3,072 3,174
Cash & Equivalents		 252 292 381 368 603 413 531 577 753 345 438
Accounts Receivable		 1,043 985 1,043 988 933 1,071 1,103 1,045 1,135 1,147 1,114
Inventories, net		 957 1,008 1,001 970 929 1,188 1,197 1,228 1,259 1,328 1,357
Other Current Assets		 198 210 197 289 212 212 206 211 245 252 265
Plant, Property, & Equipment, net		 351 379 388 380 369 424 423 411 426 433 444
Total Noncurrent Assets		 3,461 3,525 3,526 3,464 3,474 4,676 4,675 4,602 4,697 4,683 4,589
Goodwill		 2,678 2,736 2,737 2,687 2,689 3,079 3,119 3,084 3,126 3,122 3,096
Intangible Assets		 460 471 467 456 456 1,218 1,197 1,157 1,137 1,113 1,069
Other Noncurrent Operating Assets		 323 318 322 321 329 379 359 361 434 448 424
Total Liabilities & Shareholders' Equity		 6,262 6,399 6,536 6,459 6,520 7,984 8,135 8,074 8,515 8,188 8,207
Total Liabilities		 3,862 3,795 3,859 3,814 3,751 4,690 4,781 4,727 5,901 5,417 5,285
Total Current Liabilities		 1,542 1,469 1,524 1,467 1,385 1,594 1,672 1,578 3,382 1,632 1,531
Accounts Payable		 936 894 948 863 858 980 1,021 971 1,102 1,037 1,015
Accrued Expenses		 594 563 564 592 515 602 645 607 655 595 516
Total Noncurrent Liabilities		 2,320 2,326 2,335 2,347 2,366 3,096 3,109 3,149 2,519 3,785 3,754
Long-Term Debt		 1,407 1,402 1,400 1,397 1,394 1,979 1,983 1,983 1,983 3,169 3,165
Other Noncurrent Operating Liabilities		 913 924 935 950 972 1,117 1,126 1,166 536 616 589
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 2,400 2,604 2,677 2,645 2,769 3,294 3,354 3,347 2,614 2,771 2,922
Total Preferred & Common Equity		 2,400 2,604 2,677 2,645 2,769 3,294 3,354 3,347 2,614 2,771 2,922
Preferred Stock		 - - - - - 482 482 482 482 483 482
Total Common Equity		 2,400 2,604 2,677 2,645 2,769 2,812 2,872 2,865 2,132 2,290 2,440
Common Stock		 2,162 2,191 2,204 2,219 2,243 2,276 2,294 2,333 2,349 2,375 2,410
Retained Earnings		 561 657 707 728 853 881 893 904 71 218 374
Treasury Stock		 -31 -44 -50 -81 -101 -103 -108 -126 -127 -136 -176
Accumulated Other Comprehensive Income / (Loss)		 -292 -200 -184 -221 -226 -242 -207 -246 -161 -168 -168

Annual Metrics And Ratios for Resideo Technologies

This table displays calculated financial ratios and metrics derived from Resideo Technologies' official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 0.00% 1.44% 6.82% 3.34% 1.66% 15.28% 8.96% -2.01% 8.31% 10.52%
EBITDA Growth		 0.00% -37.70% -18.45% 15.79% 13.64% 95.20% 15.98% -15.90% -6.30% -128.48%
EBIT Growth		 0.00% -46.45% -25.30% 12.90% 17.14% 143.90% 18.00% -19.92% -20.11% -206.62%
NOPAT Growth		 0.00% -473.71% 281.77% -93.19% -12.91% 236.37% 7.94% -11.28% -25.63% 55.67%
Net Income Growth		 0.00% -322.60% 202.79% -91.11% 2.78% 554.05% 16.94% -25.80% -44.76% -554.31%
EPS Growth		 0.00% -323.61% 202.48% -91.21% 0.00% 462.07% 16.56% -25.26% -57.04% -718.03%
Operating Cash Flow Growth		 0.00% -75.50% 1,148.65% -95.02% 960.87% 29.10% -51.75% 189.47% 0.91% -356.08%
Free Cash Flow Firm Growth		 0.00% 0.00% 155.45% -103.01% 325.86% 131.16% -258.59% 195.72% -271.50% 51.34%
Invested Capital Growth		 0.00% 0.00% -3.06% 7.74% -0.83% 2.62% 33.69% -3.04% 31.09% 17.89%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.77% 4.04% -0.80% 1.69% -0.37% 4.98% 0.50%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% -33.33% 212.50% 0.00% -3.90% 7.45% -5.51% 52.08%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% -45.74% 1,922.22% 0.25% -5.41% 8.93% -12.97% 29.39%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% -12.30% -29.54% -0.01% -8.48% 24.44% -17.39% -0.65%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% -40.98% 219.35% 3.42% -9.00% 25.75% -33.71% 17.66%
EPS Q/Q Growth		 0.00% 0.00% 0.00% -40.82% 211.54% -1.81% -8.65% 25.66% -45.05% 19.79%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 99.14% 35.29% 31.89% -11.27% 21.60% 39.24% -11.90% 7.79%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% -27.96% -9.26% -21.24% 171.15% -2.82% -12.05%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% -1.26% -1.09% 0.11% 1.46% -4.80% -4.41% -3.07%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 30.64% 29.12% 29.52% 25.60% 26.50% 27.10% 27.72% 27.17% 28.12% 29.39%
EBITDA Margin		 8.40% 5.16% 3.94% 4.41% 4.93% 8.35% 8.89% 7.63% 6.60% -1.70%
Operating Margin		 11.11% 9.85% 10.21% 5.17% 6.13% 9.56% 9.59% 8.76% 7.69% 8.12%
EBIT Margin		 6.96% 3.67% 2.57% 2.81% 3.23% 6.84% 7.41% 6.06% 4.47% -4.31%
Profit (Net Income) Margin		 3.97% -8.72% 8.39% 0.72% 0.73% 4.14% 4.44% 3.36% 1.72% -7.05%
Tax Burden Percent		 57.10% -237.35% 389.42% 50.70% 36.63% 68.56% 67.70% 67.09% 52.49% 115.32%
Interest Burden Percent		 100.00% 100.00% 83.87% 50.71% 61.59% 88.25% 88.56% 82.80% 73.18% 141.93%
Effective Tax Rate		 42.90% 337.35% -289.42% 49.30% 63.37% 31.44% 32.30% 32.91% 47.51% 0.00%
Return on Invested Capital (ROIC)		 0.00% -82.94% 76.55% 5.10% 4.30% 14.34% 13.08% 10.30% 6.73% 8.48%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -2,447.95% -267.74% -4.41% -4.73% -11.34% -3.84% -6.68% -8.57% -41.66%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 52.66% -56.97% -2.80% -2.24% -2.94% -1.24% -2.34% -2.90% -25.41%
Return on Equity (ROE)		 0.00% -30.27% 19.58% 2.30% 2.06% 11.40% 11.84% 7.96% 3.83% -16.93%
Cash Return on Invested Capital (CROIC)		 0.00% -282.94% 79.66% -2.35% 5.13% 11.76% -15.76% 13.38% -20.18% -7.94%
Operating Return on Assets (OROA)		 0.00% 3.71% 2.63% 2.77% 3.05% 6.98% 7.71% 5.80% 4.07% -3.87%
Return on Assets (ROA)		 0.00% -8.81% 8.58% 0.71% 0.69% 4.22% 4.62% 3.22% 1.56% -6.34%
Return on Common Equity (ROCE)		 0.00% -30.27% 19.58% 2.30% 2.06% 11.40% 11.84% 7.96% 3.52% -14.31%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -15.14% 26.42% 2.25% 1.86% 10.75% 11.19% 7.64% 3.51% 0.00%
Net Operating Profit after Tax (NOPAT)		 283 -1,056 1,920 131 114 383 414 367 273 425
NOPAT Margin		 6.34% -23.37% 39.77% 2.62% 2.25% 6.56% 6.49% 5.88% 4.04% 5.69%
Net Nonoperating Expense Percent (NNEP)		 0.00% 2,365.02% 344.29% 9.51% 9.03% 25.68% 16.91% 16.97% 15.30% 50.14%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - 10.49% 8.85% 5.16% 6.98%
Cost of Revenue to Revenue		 69.36% 70.88% 70.48% 74.40% 73.50% 72.90% 72.28% 72.83% 71.88% 70.61%
SG&A Expenses to Revenue		 19.53% 19.27% 19.31% 18.68% 17.53% 15.55% 15.29% 15.38% 16.83% 16.94%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 1.46% 1.47% 1.74% 1.75% 1.64% 2.24%
Operating Expenses to Revenue		 19.53% 19.27% 19.31% 20.43% 20.37% 17.53% 18.13% 18.41% 20.43% 21.27%
Earnings before Interest and Taxes (EBIT)		 310 166 124 140 164 400 472 378 302 -322
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 374 233 190 220 250 488 566 476 446 -127
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 1.65 0.91 1.32 1.67 0.95 1.00 1.20 2.16
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.52 0.29 0.52 0.64 0.38 0.44 0.50 0.70
Price to Earnings (P/E)		 0.00 0.00 6.24 40.70 70.96 15.53 8.48 13.09 37.23 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 16.03% 2.46% 1.41% 6.44% 11.80% 7.64% 2.69% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 1.40 0.95 1.24 1.56 0.96 1.00 1.12 1.52
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.72 0.51 0.64 0.72 0.55 0.56 0.76 1.10
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 18.23 11.47 13.08 8.63 6.16 7.37 11.57 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 27.93 18.02 19.94 10.53 7.39 9.28 17.09 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 1.80 19.29 28.71 10.99 8.43 9.56 18.91 19.41
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 7.50 109.71 13.40 13.38 22.95 7.98 11.62 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 1.73 0.00 24.06 13.41 0.00 7.36 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.78 0.74 0.58 0.55 0.56 0.51 0.60 1.09
Long-Term Debt to Equity		 0.00 0.00 0.77 0.72 0.58 0.54 0.56 0.51 0.60 1.09
Financial Leverage		 0.00 -0.02 0.21 0.64 0.47 0.26 0.32 0.35 0.34 0.61
Leverage Ratio		 0.00 1.72 2.28 3.22 2.99 2.70 2.56 2.47 2.45 2.67
Compound Leverage Factor		 0.00 1.72 1.92 1.63 1.84 2.38 2.27 2.04 1.79 3.79
Debt to Total Capital		 0.00% 0.00% 43.93% 42.42% 36.83% 35.32% 35.89% 33.68% 37.47% 52.05%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.80% 0.79% 0.22% 0.29% 0.30% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 43.12% 41.62% 36.61% 35.04% 35.59% 33.68% 37.47% 52.05%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 9.11% 7.92%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 100.00% 56.07% 57.58% 63.17% 64.68% 64.11% 66.32% 53.42% 40.02%
Debt to EBITDA		 0.00 0.00 6.32 5.36 4.65 2.52 2.50 2.93 4.45 -24.94
Net Debt to EBITDA		 0.00 0.00 4.93 4.81 2.58 0.93 1.93 1.60 2.89 -19.73
Long-Term Debt to EBITDA		 0.00 0.00 6.21 5.26 4.62 2.50 2.48 2.93 4.45 -24.94
Debt to NOPAT		 0.00 0.00 0.63 9.02 10.20 3.21 3.42 3.80 7.27 7.45
Net Debt to NOPAT		 0.00 0.00 0.49 8.09 5.66 1.19 2.64 2.07 4.73 5.90
Long-Term Debt to NOPAT		 0.00 0.00 0.61 8.85 10.14 3.18 3.39 3.80 7.27 7.45
Altman Z-Score		 0.00 0.00 1.57 1.39 1.60 2.14 1.93 1.94 1.72 1.62
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 7.96% 15.48%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 0.00 1.21 1.21 1.19 1.45 1.70 1.62 1.80 1.77 1.91
Quick Ratio		 0.00 0.75 0.73 0.63 0.90 1.11 0.86 1.06 0.96 0.99
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -3,603 1,998 -60 136 314 -498 477 -818 -398
Operating Cash Flow to CapEx		 251.67% 72.55% 570.37% 24.21% 348.57% 500.00% 178.82% 419.05% 555.00% -980.17%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 99.89 -0.87 2.16 6.69 -9.23 7.34 -10.10 -2.95
Operating Cash Flow to Interest Expense		 0.00 0.00 23.10 0.33 3.87 6.70 2.81 6.77 5.48 -8.42
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 19.05 -1.04 2.76 5.36 1.24 5.15 4.49 -9.28
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.00 1.01 1.02 0.99 0.94 1.02 1.04 0.96 0.91 0.90
Accounts Receivable Turnover		 0.00 5.63 5.95 6.09 6.04 6.72 6.78 6.32 6.77 7.13
Inventory Turnover		 0.00 6.89 6.23 5.71 5.55 6.04 5.37 4.75 4.46 4.07
Fixed Asset Turnover		 0.00 17.05 17.09 16.19 16.00 19.33 19.51 16.51 16.90 17.44
Accounts Payable Turnover		 0.00 4.34 4.00 3.94 4.02 4.69 5.18 5.05 4.91 4.79
Days Sales Outstanding (DSO)		 0.00 64.78 61.36 59.93 60.46 54.29 53.80 57.74 53.88 51.19
Days Inventory Outstanding (DIO)		 0.00 52.99 58.63 63.88 65.76 60.46 67.98 76.92 81.79 89.62
Days Payable Outstanding (DPO)		 0.00 84.10 91.30 92.65 90.88 77.89 70.44 72.22 74.28 76.24
Cash Conversion Cycle (CCC)		 0.00 33.67 28.69 31.16 35.34 36.86 51.35 62.44 61.39 64.58
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 0.00 2,547 2,469 2,660 2,638 2,707 3,619 3,509 4,600 5,423
Invested Capital Turnover		 0.00 3.55 1.92 1.95 1.91 2.19 2.01 1.75 1.67 1.49
Increase / (Decrease) in Invested Capital		 0.00 2,547 -78 191 -22 69 912 -110 1,091 823
Enterprise Value (EV)		 0.00 0.00 3,463 2,523 3,271 4,213 3,489 3,509 5,161 8,246
Market Capitalization		 0.00 0.00 2,527 1,465 2,626 3,758 2,399 2,749 3,388 5,258
Book Value per Share		 $0.00 $21.25 $12.47 $13.04 $16.14 $15.60 $17.34 $18.82 $19.24 $16.26
Tangible Book Value per Share		 $0.00 ($1.51) ($10.04) ($8.47) ($5.65) ($3.66) ($4.59) ($2.85) ($9.67) ($11.73)
Total Capital		 0.00 2,603 2,734 2,782 3,155 3,482 3,945 4,145 5,292 6,084
Total Debt		 0.00 0.00 1,201 1,180 1,162 1,230 1,416 1,396 1,983 3,167
Total Long-Term Debt		 0.00 0.00 1,179 1,158 1,155 1,220 1,404 1,396 1,983 3,167
Net Debt		 0.00 -56 936 1,058 645 455 1,090 760 1,291 2,506
Capital Expenditures (CapEx)		 60 51 81 95 70 63 85 105 80 116
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 189 77 191 177 282 642 582 690 942
Debt-free Net Working Capital (DFNWC)		 0.00 245 342 313 694 1,057 968 1,218 1,382 1,603
Net Working Capital (NWC)		 0.00 245 320 291 687 1,047 956 1,218 1,382 1,603
Net Nonoperating Expense (NNE)		 106 -662 1,515 95 77 141 131 157 157 952
Net Nonoperating Obligations (NNO)		 0.00 -56 936 1,058 645 455 1,090 760 1,291 2,506
Total Depreciation and Amortization (D&A)		 64 67 66 80 86 88 94 98 144 195
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 4.18% 1.60% 3.83% 3.49% 4.82% 10.08% 9.32% 10.21% 12.61%
Debt-free Net Working Capital to Revenue		 0.00% 5.42% 7.09% 6.28% 13.69% 18.08% 15.20% 19.51% 20.44% 21.45%
Net Working Capital to Revenue		 0.00% 5.42% 6.63% 5.83% 13.55% 17.91% 15.01% 19.51% 20.44% 21.45%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $3.31 $0.29 $0.30 $1.68 $1.94 $1.43 $0.62 ($3.77)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 122.50M 122.72M 125.35M 144.04M 146M 147M 146M 149M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $3.30 $0.29 $0.29 $1.63 $1.90 $1.42 $0.61 ($3.77)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 122.62M 123.24M 126.32M 148.45M 149M 148M 149M 149M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 122.69M 122.94M 143.14M 145.02M 146.62M 145.32M 147.88M 151.25M
Normalized Net Operating Profit after Tax (NOPAT)		 283 312 345 131 246 383 437 395 300 436
Normalized NOPAT Margin		 6.34% 6.89% 7.15% 2.62% 4.85% 6.56% 6.87% 6.33% 4.44% 5.84%
Pre Tax Income Margin		 6.96% 3.67% 2.15% 1.42% 1.99% 6.04% 6.56% 5.01% 3.27% -6.12%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 6.20 2.03 2.60 8.51 8.74 5.82 3.73 -2.39
NOPAT to Interest Expense		 0.00 0.00 95.99 1.90 1.81 8.15 7.66 5.65 3.37 3.15
EBIT Less CapEx to Interest Expense		 0.00 0.00 2.15 0.65 1.49 7.17 7.17 4.20 2.74 -3.24
NOPAT Less CapEx to Interest Expense		 0.00 0.00 91.94 0.52 0.70 6.81 6.09 4.03 2.38 2.29
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 10.34% -6.64%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 19.52% 11.21% -6.64%

Quarterly Metrics And Ratios for Resideo Technologies

This table displays calculated financial ratios and metrics derived from Resideo Technologies' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/30/2024 6/29/2024 9/28/2024 12/31/2024 3/29/2025 6/28/2025 9/27/2025 12/31/2025 4/4/2026
DEI Shares Outstanding		 - - - - - - - - - - 151,247,101.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 151,247,101.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 0.17
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -3.96% -1.47% -4.07% -0.81% 17.63% 20.88% 19.11% 22.28% 1.97% 1.99% 8.02%
EBITDA Growth		 -44.44% 30.00% -9.84% -25.00% 56.00% -18.18% -20.91% -751.96% 67.52% 117.95% 75.86%
EBIT Growth		 -52.25% 36.47% -12.24% -33.33% 33.96% -38.79% -53.49% -1,064.86% 107.04% 188.73% 155.00%
NOPAT Growth		 -39.18% 118.58% -22.36% -23.78% -7.42% -38.33% -27.85% 99.73% 281.33% 65.83% 29.55%
Net Income Growth		 -66.67% 110.26% -24.56% -40.00% -4.76% -71.95% -86.05% -2,850.00% 680.00% 491.30% 533.33%
EPS Growth		 -66.67% 107.41% -23.68% -44.12% -50.00% -89.29% -106.90% -3,042.11% 1,114.29% 1,550.00% 950.00%
Operating Cash Flow Growth		 62.16% 89.21% 150.00% -23.97% 145.00% -22.81% -3,350.00% 117.39% -1,168.71% 47.29% -123.08%
Free Cash Flow Firm Growth		 92.49% 126.75% 361.01% -1,688.41% -1,770.53% -543.61% -591.11% 204.53% 47.17% 31.10% 26.72%
Invested Capital Growth		 3.34% -3.04% -4.13% 31.39% 30.55% 31.09% 33.06% -21.10% 16.27% 17.89% 18.85%
Revenue Q/Q Growth		 -3.00% -1.09% -3.32% 6.93% 15.04% 1.64% -4.74% 9.77% -4.07% 1.66% 0.90%
EBITDA Q/Q Growth		 -44.85% 90.67% -23.08% -7.27% 14.71% 0.00% -25.64% -864.37% 129.47% 30.10% -40.00%
EBIT Q/Q Growth		 -52.25% 118.87% -25.86% -13.95% -4.05% 0.00% -43.66% -1,885.00% 120.59% 39.46% -50.24%
NOPAT Q/Q Growth		 -23.98% 92.91% -36.82% -17.72% -7.68% 28.51% -26.09% 127.76% 76.27% -44.12% -42.26%
Net Income Q/Q Growth		 -58.00% 290.48% -47.56% -30.23% -33.33% 15.00% -73.91% -13,850.00% 118.91% -12.82% -72.06%
EPS Q/Q Growth		 -58.82% 300.00% -48.21% -34.48% -63.16% -14.29% -133.33% -27,850.00% 115.21% 16.47% -82.83%
Operating Cash Flow Q/Q Growth		 -50.41% 338.33% -99.24% 4,500.00% 59.78% 38.10% -132.02% 407.69% -885.50% 119.03% -148.50%
Free Cash Flow Firm Q/Q Growth		 7.27% 501.41% 5.54% -580.37% 3.02% 4.80% -10.73% 202.25% -149.01% -24.15% -17.77%
Invested Capital Q/Q Growth		 -0.59% -4.80% 1.45% 36.39% -1.23% -4.41% 3.33% -19.12% 45.55% -3.07% 4.17%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 26.83% 27.65% 26.92% 28.13% 28.67% 28.53% 28.87% 29.28% 29.83% 29.55% 28.82%
EBITDA Margin		 4.83% 9.30% 7.40% 6.42% 6.40% 6.30% 4.92% -34.23% 10.52% 13.46% 8.00%
Operating Margin		 7.01% 9.56% 8.61% 7.68% 6.89% 7.75% 7.68% 9.11% 8.26% 7.39% 5.33%
EBIT Margin		 3.41% 7.55% 5.79% 4.66% 3.88% 3.82% 2.26% -36.75% 7.89% 10.82% 5.33%
Profit (Net Income) Margin		 1.35% 5.34% 2.89% 1.89% 1.09% 1.24% 0.34% -42.46% 8.37% 7.18% 1.99%
Tax Burden Percent		 56.76% 81.19% 58.90% 50.85% 45.45% 51.11% 40.00% 111.79% 141.82% 87.18% 69.09%
Interest Burden Percent		 69.81% 87.07% 84.88% 79.73% 61.97% 63.38% 37.50% 103.36% 74.83% 76.10% 53.92%
Effective Tax Rate		 43.24% 18.81% 41.10% 49.15% 54.55% 48.89% 60.00% 0.00% -41.82% 12.82% 30.91%
Return on Invested Capital (ROIC)		 6.88% 13.60% 8.59% 5.61% 4.75% 6.61% 5.20% 10.83% 16.74% 9.60% 5.40%
ROIC Less NNEP Spread (ROIC-NNEP)		 3.18% 9.56% 5.23% 3.16% 1.77% 1.67% 0.82% -56.76% 13.83% 10.34% 3.82%
Return on Net Nonoperating Assets (RNNOA)		 1.39% 3.35% 1.87% 1.38% 0.74% 0.57% 0.30% -26.98% 9.67% 6.30% 2.52%
Return on Equity (ROE)		 8.27% 16.95% 10.46% 6.99% 5.48% 7.17% 5.50% -16.15% 26.41% 15.91% 7.92%
Cash Return on Invested Capital (CROIC)		 4.85% 13.38% 13.68% -19.44% -18.72% -20.18% -22.22% 32.95% -6.83% -7.94% -9.52%
Operating Return on Assets (OROA)		 3.36% 7.23% 5.54% 3.96% 3.43% 3.48% 2.18% -32.96% 7.18% 9.72% 4.99%
Return on Assets (ROA)		 1.33% 5.11% 2.77% 1.60% 0.97% 1.13% 0.33% -38.08% 7.62% 6.45% 1.86%
Return on Common Equity (ROCE)		 8.27% 16.95% 10.46% 6.43% 5.04% 6.60% 5.06% -13.52% 22.25% 13.44% 6.70%
Return on Equity Simple (ROE_SIMPLE)		 6.31% 0.00% 7.08% 5.34% 5.22% 0.00% 2.36% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 62 119 75 62 57 74 54 124 218 122 70
NOPAT Margin		 3.98% 7.76% 5.07% 3.90% 3.13% 3.96% 3.07% 6.38% 11.72% 6.44% 3.69%
Net Nonoperating Expense Percent (NNEP)		 3.70% 4.04% 3.37% 2.46% 2.98% 4.93% 4.38% 67.59% 2.91% -0.73% 1.57%
Return On Investment Capital (ROIC_SIMPLE)		 - 2.88% - - - 1.39% 1.02% 2.70% 3.68% 2.01% 1.16%
Cost of Revenue to Revenue		 73.17% 72.35% 73.08% 71.87% 71.33% 71.47% 71.13% 70.72% 70.17% 70.45% 71.18%
SG&A Expenses to Revenue		 14.99% 15.68% 15.55% 17.62% 17.34% 16.68% 17.29% 16.42% 17.38% 16.73% 17.78%
R&D to Revenue		 1.80% 1.76% 1.68% 1.32% 1.26% 2.26% 1.98% 2.11% 2.36% 2.48% 2.51%
Operating Expenses to Revenue		 19.82% 18.09% 18.30% 20.45% 21.77% 20.78% 21.19% 20.18% 21.57% 22.16% 23.48%
Earnings before Interest and Taxes (EBIT)		 53 116 86 74 71 71 40 -714 147 205 102
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 75 143 110 102 117 117 87 -665 196 255 153
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.88 1.00 1.18 1.02 1.02 1.20 0.92 1.56 2.69 2.16 2.15
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.37 0.44 0.53 0.46 0.46 0.50 0.37 0.45 0.83 0.70 0.69
Price to Earnings (P/E)		 13.97 13.09 16.71 16.23 17.67 37.23 58.56 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 7.16% 7.64% 5.98% 6.16% 5.66% 2.69% 1.71% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.92 1.00 1.14 1.01 1.01 1.12 0.95 1.31 1.69 1.52 1.50
Enterprise Value to Revenue (EV/Rev)		 0.54 0.56 0.66 0.80 0.76 0.76 0.64 0.68 1.27 1.10 1.11
Enterprise Value to EBITDA (EV/EBITDA)		 7.62 7.37 8.79 11.43 10.32 11.57 10.69 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 9.72 9.28 11.14 14.94 14.04 17.09 17.67 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 11.44 9.56 11.82 14.90 14.75 18.91 17.68 12.37 22.11 19.41 21.06
Enterprise Value to Operating Cash Flow (EV/OCF)		 10.68 7.98 9.14 11.79 9.67 11.62 12.00 10.41 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 19.18 7.36 8.17 0.00 0.00 0.00 0.00 3.51 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.53 0.51 0.51 0.60 0.59 0.60 0.59 0.76 1.14 1.09 1.08
Long-Term Debt to Equity		 0.53 0.51 0.50 0.60 0.59 0.60 0.59 0.76 1.14 1.09 1.08
Financial Leverage		 0.44 0.35 0.36 0.44 0.42 0.34 0.36 0.48 0.70 0.61 0.66
Leverage Ratio		 2.52 2.47 2.40 2.43 2.43 2.45 2.39 2.79 2.67 2.67 2.60
Compound Leverage Factor		 1.76 2.15 2.04 1.94 1.51 1.55 0.89 2.89 1.99 2.03 1.40
Debt to Total Capital		 34.76% 33.68% 33.68% 37.67% 37.23% 37.47% 37.20% 43.14% 53.35% 52.05% 52.00%
Short-Term Debt to Total Capital		 0.30% 0.00% 0.29% 0.23% 0.11% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 34.46% 33.68% 33.39% 37.45% 37.11% 37.47% 37.20% 43.14% 53.35% 52.05% 52.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 9.12% 9.02% 9.11% 9.04% 10.49% 8.12% 7.92% 7.92%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 65.24% 66.32% 66.32% 53.21% 53.75% 53.42% 53.75% 46.38% 38.54% 40.02% 40.09%
Debt to EBITDA		 3.18 2.93 3.03 4.63 4.21 4.45 4.69 -5.76 -11.96 -24.94 -51.89
Net Debt to EBITDA		 2.35 1.60 1.73 3.67 3.09 2.89 3.32 -3.58 -10.66 -19.73 -44.70
Long-Term Debt to EBITDA		 3.15 2.93 3.00 4.60 4.20 4.45 4.69 -5.76 -11.96 -24.94 -51.89
Debt to NOPAT		 4.78 3.80 4.07 6.04 6.02 7.27 7.75 4.86 7.41 7.45 7.89
Net Debt to NOPAT		 3.53 2.07 2.33 4.78 4.41 4.73 5.49 3.01 6.60 5.90 6.80
Long-Term Debt to NOPAT		 4.74 3.80 4.04 6.00 6.00 7.27 7.75 4.86 7.41 7.45 7.89
Altman Z-Score		 1.74 1.81 1.94 1.52 1.54 1.63 1.60 0.94 1.90 1.82 1.87
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 8.07% 8.03% 7.96% 7.88% 16.32% 15.73% 15.48% 15.38%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.78 1.80 1.93 1.81 1.82 1.77 1.94 1.00 1.88 1.91 2.07
Quick Ratio		 0.92 1.06 1.11 0.93 0.98 0.96 1.03 0.56 0.91 0.99 1.01
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -57 229 229 -1,102 -1,069 -1,017 -1,127 1,152 -565 -701 -826
Operating Cash Flow to CapEx		 240.00% 848.39% 9.52% 613.33% 668.18% 922.73% -209.68% 1,000.00% -5,610.71% 808.11% -402.78%
Free Cash Flow to Firm to Interest Expense		 -3.57 15.29 17.65 -73.46 -39.58 -39.13 -45.06 48.00 -15.26 -14.31 -17.56
Operating Cash Flow to Interest Expense		 3.75 17.53 0.15 6.13 5.44 7.81 -2.60 8.33 -42.46 6.10 -3.09
Operating Cash Flow Less CapEx to Interest Expense		 2.19 15.47 -1.46 5.13 4.63 6.96 -3.84 7.50 -43.22 5.35 -3.85
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.99 0.96 0.96 0.85 0.88 0.91 0.97 0.90 0.91 0.90 0.94
Accounts Receivable Turnover		 6.17 6.32 6.44 5.83 6.16 6.77 7.12 6.71 6.61 7.13 7.05
Inventory Turnover		 4.74 4.75 4.65 4.09 4.29 4.46 4.67 4.30 4.17 4.07 4.16
Fixed Asset Turnover		 17.14 16.51 16.52 15.19 16.04 16.90 18.06 17.41 17.37 17.44 17.81
Accounts Payable Turnover		 5.07 5.05 5.14 4.64 4.93 4.91 5.50 5.06 5.12 4.79 5.42
Days Sales Outstanding (DSO)		 59.16 57.74 56.65 62.57 59.26 53.88 51.24 54.41 55.23 51.19 51.75
Days Inventory Outstanding (DIO)		 77.07 76.92 78.54 89.23 85.16 81.79 78.21 84.82 87.46 89.62 87.72
Days Payable Outstanding (DPO)		 71.95 72.22 71.04 78.59 74.04 74.28 66.32 72.17 71.28 76.24 67.39
Cash Conversion Cycle (CCC)		 64.28 62.44 64.15 73.21 70.38 61.39 63.13 67.06 71.40 64.58 72.08
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 3,686 3,509 3,572 4,872 4,812 4,600 4,753 3,844 5,595 5,423 5,649
Invested Capital Turnover		 1.73 1.75 1.69 1.44 1.52 1.67 1.69 1.70 1.43 1.49 1.46
Increase / (Decrease) in Invested Capital		 119 -110 -154 1,164 1,126 1,091 1,181 -1,028 783 823 896
Enterprise Value (EV)		 3,374 3,509 4,078 4,916 4,873 5,161 4,523 5,047 9,455 8,246 8,448
Market Capitalization		 2,333 2,749 3,275 2,856 2,933 3,388 2,635 3,335 6,148 5,258 5,239
Book Value per Share		 $17.91 $18.82 $18.97 $19.26 $19.62 $19.24 $19.37 $14.36 $15.39 $16.26 $16.13
Tangible Book Value per Share		 ($3.37) ($2.85) ($2.58) ($10.17) ($9.86) ($9.67) ($9.31) ($14.35) ($13.08) ($11.73) ($11.41)
Total Capital		 4,054 4,145 4,175 5,285 5,343 5,292 5,330 4,597 5,940 6,084 6,087
Total Debt		 1,409 1,396 1,406 1,991 1,989 1,983 1,983 1,983 3,169 3,167 3,165
Total Long-Term Debt		 1,397 1,396 1,394 1,979 1,983 1,983 1,983 1,983 3,169 3,167 3,165
Net Debt		 1,041 760 803 1,578 1,458 1,291 1,406 1,230 2,824 2,506 2,727
Capital Expenditures (CapEx)		 25 31 21 15 22 22 31 20 28 37 36
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 792 582 701 889 840 690 906 -743 1,095 942 1,205
Debt-free Net Working Capital (DFNWC)		 1,160 1,218 1,304 1,302 1,371 1,382 1,483 10 1,440 1,603 1,643
Net Working Capital (NWC)		 1,148 1,218 1,292 1,290 1,365 1,382 1,483 10 1,440 1,603 1,643
Net Nonoperating Expense (NNE)		 41 37 32 32 37 51 48 949 62 -14 32
Net Nonoperating Obligations (NNO)		 1,041 760 803 1,578 1,458 1,291 1,406 1,230 2,824 2,506 2,727
Total Depreciation and Amortization (D&A)		 22 27 24 28 46 46 47 49 49 50 51
Debt-free, Cash-free Net Working Capital to Revenue		 12.64% 9.32% 11.34% 14.42% 13.04% 10.21% 12.86% -10.04% 14.73% 12.61% 15.83%
Debt-free Net Working Capital to Revenue		 18.52% 19.51% 21.10% 21.12% 21.29% 20.44% 21.05% 0.14% 19.37% 21.45% 21.58%
Net Working Capital to Revenue		 18.32% 19.51% 20.91% 20.92% 21.20% 20.44% 21.05% 0.14% 19.37% 21.45% 21.58%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.14 $0.56 $0.29 $0.19 $0.07 $0.07 ($0.02) ($5.59) $0.88 $0.96 $0.17
Adjusted Weighted Average Basic Shares Outstanding		 147M 147M 146M 146M 147M 146M 148M 149M 149M 149M 151M
Adjusted Diluted Earnings per Share		 $0.14 $0.56 $0.29 $0.19 $0.07 $0.06 ($0.02) ($5.59) $0.85 $0.99 $0.17
Adjusted Weighted Average Diluted Shares Outstanding		 148M 148M 148M 149M 149M 149M 148M 149M 154M 149M 155M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 146.09M 145.32M 146.02M 146.41M 146.97M 147.88M 148.50M 148.76M 149.71M 151.25M 151.43M
Normalized Net Operating Profit after Tax (NOPAT)		 83 119 80 68 109 74 98 125 110 128 91
Normalized NOPAT Margin		 5.37% 7.76% 5.35% 4.26% 5.94% 3.96% 5.54% 6.45% 5.90% 6.76% 4.77%
Pre Tax Income Margin		 2.38% 6.57% 4.91% 3.71% 2.41% 2.42% 0.85% -37.98% 5.90% 8.23% 2.88%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 3.31 7.73 6.62 4.93 2.63 2.73 1.60 -29.75 3.97 4.18 2.17
NOPAT to Interest Expense		 3.87 7.96 5.80 4.14 2.12 2.83 2.18 5.16 5.90 2.49 1.50
EBIT Less CapEx to Interest Expense		 1.75 5.67 5.00 3.93 1.81 1.88 0.36 -30.58 3.22 3.43 1.40
NOPAT Less CapEx to Interest Expense		 2.30 5.89 4.18 3.14 1.31 1.98 0.94 4.33 5.15 1.74 0.73
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 10.34% 26.58% -3.74% -5.47% -6.64% -7.07%
Augmented Payout Ratio		 16.77% 19.52% 21.43% 0.00% 8.00% 11.21% 26.58% -3.74% -5.47% -6.64% -7.07%

Financials Breakdown Chart

Key Financial Trends

Resideo Technologies (NYSE: REZI) has shown relatively stable top-line performance in the last four years, with quarterly revenue generally in the $1.5–$2.0 billion range. Gross margins have stayed in the high-20s to low-30s, and operating profitability has been supported by a mix of moderate SG&A, R&D, and amortization expense. 2025 brought some volatility, including a large negative quarterly swing in mid-year driven by non-operating items, but late-2025 results improved with a solid Q4 showing positive net income to common and a strong cash-flow infusion. The company remains financially leveraged, with meaningful debt on the balance sheet, and cash flows have fluctuated quarter to quarter. Investors should weigh the improving near-term profitability and cash generation against the higher leverage and episodic earnings volatility observed over the period.

  • Revenue stability and modest growth in late 2025: Q4 2025 revenue was $1.895B, up modestly from Q4 2024’s $1.858B, signaling continued demand in the core business.
  • Healthy gross margins maintained: Q4 2025 gross margin around 29.6% (560M gross profit on 1.895B revenue), consistent with recent quarters.
  • Bottom-line improvement in the latest quarter: Net income attributable to common shareholders reached $143M in Q4 2025, with diluted EPS about $0.99, versus much smaller or negative earnings in earlier periods.
  • Strong cash generation in Q4 2025: Net cash from continuing operating activities was $299M, with capex of $37M, implying roughly $262M of free cash flow for the quarter.
  • Solid equity base: Total common equity around $2.29B in 2025 (Q3), providing a reasonable equity buffer relative to debt load.
  • Debt load remains elevated: Long-term debt around $3.17B and total liabilities ≈$5.42B (Q3 2025), yielding a fairly high leverage profile that could pressure financial flexibility during downturns.
  • EPS and quarterly variability: Earnings per share and quarterly results have shown variability across quarters, with some quarters modestly positive and others less so, reflecting seasonality and non-operating effects.
  • Significant quarterly earnings volatility in 2025: Q2 2025 showed a large net loss to common (approximately -$833M to common shareholders, with a substantial negative pretax and a big negative swing from non-operating items), highlighting earnings volatility driven by one-off or non-operating factors.
  • Cash-flow volatility in mid-2025: Q3 2025 featured a negative net cash from continuing operating activities (about -$1.57B), indicating substantial working capital or non-operating headwinds during that quarter.
  • Debt-funded financing activity: The 2025 Q3 period included a large debt issuance (about $1.21B) to fund financing activities, underscoring ongoing reliance on leverage to support liquidity and growth needs.
05/28/26 12:14 PM ETAI Generated. May Contain Errors.

Resideo Technologies Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Resideo Technologies' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Resideo Technologies' net income appears to be on a downward trend, with a most recent value of -$527 million in 2025, falling from $177 million in 2016. The previous period was $116 million in 2024. Find out what analysts predict for Resideo Technologies in the coming months.

Resideo Technologies' total operating income in 2025 was $607 million, based on the following breakdown:
  • Total Gross Profit: $2.20 billion
  • Total Operating Expenses: $1.59 billion

Over the last 9 years, Resideo Technologies' total revenue changed from $4.46 billion in 2016 to $7.47 billion in 2025, a change of 67.7%.

Resideo Technologies' total liabilities were at $5.52 billion at the end of 2025, a 12.8% increase from 2024, and a 195.0% increase since 2017.

In the past 8 years, Resideo Technologies' cash and equivalents has ranged from $56 million in 2017 to $775 million in 2021, and is currently $661 million as of their latest financial filing in 2025.

Over the last 9 years, Resideo Technologies' book value per share changed from 0.00 in 2016 to 16.26 in 2025, a change of 1,626.4%.


Related Companies

Financial statements for NYSE:REZI last updated on 5/13/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
BNZI Breakout Watch: AI Growth Meets Turnaround Setup!
Banzai International (NASDAQ: BNZI) reported full-year 2025 revenue of $12.2 million, up 169% year-over-year, ...
Huge Alerts | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
The math on the SpaceX IPO is broken
SpaceX is expected to go public at a $1.75 trillion valuation. For investors to see a 10x return, the company ...
Weiss Ratings | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
One page of the SpaceX S-1 will move this stock overnight
When SpaceX files its S-1 in June, the SEC will require full disclosure of operating expenses - including powe...
Behind the Markets | Sponsoredtc pixel
I paid $5,000 to hear Elon say this
One investor paid $5,000 to be in a private room with Elon Musk in Los Angeles - and what he heard confirmed a...
InvestorPlace | Sponsoredtc pixel
This Tech Could Be Bigger Than Apple, Amazon, and Microsoft Combined
A breakthrough technology backed by Elon Musk, Sam Altman, and Nvidia CEO Jensen Huang may hold the answer to ...
Altimetry | Sponsoredtc pixel
SMX Could Be One of the Most Interesting Small Caps Right Now
SMX (Security Matters) Public Limited is developing molecular-level markers embedded into plastics, fuels, met...
Smallcaps Daily | Sponsoredtc pixel